Cargando…

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin

Generic forms of chemically-derived drugs must exhibit chemical identity and be bioequivalent in healthy human subjects. The use of generic drugs results in a considerable savings of healthcare expenditures. Biologic drugs are produced in living systems or are derived from biologic material and exte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeske, Walter, Walenga, Jeanine M, Hoppensteadt, Debra, Fareed, Jawed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684140/ https://www.ncbi.nlm.nih.gov/pubmed/23788840 http://dx.doi.org/10.2147/DHPS.S28813

Ejemplares similares

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin
por: Jeske, Walter, et al.
Publicado: (2018)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018)

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels
por: Jeske, Walter, et al.
Publicado: (2019)

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
por: Zhou, Xin, et al.
Publicado: (2021)

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
por: O’Hara, Alexander, et al.
Publicado: (2023)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
por: Kantarcioglu, Bulent, et al.
Publicado: (2021)

Identification of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients Implanted With a Continuous-Flow Left Ventricular Assist Device
por: McClane, Nathan, et al.
Publicado: (2018)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins
por: Kouta, Ahmed, et al.
Publicado: (2019)

Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates
por: Kouta, Ahmed, et al.
Publicado: (2020)

Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates
por: Kouta, Ahmed, et al.
Publicado: (2021)

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies
por: Papageorgiou, Chrysoula, et al.
Publicado: (2018)

Heparan sulphate inhibition of cell proliferation induced by TGFβ and PDGF
por: Silber, lan E., et al.
Publicado: (1993)

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
por: Olson, Guy, et al.
Publicado: (2023)

International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation
por: Walborn, Amanda, et al.
Publicado: (2018)

Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
por: Walborn, Amanda, et al.
Publicado: (2020)

Bioequivalence of a biosimilar enoxaparin sodium to Clexane(®) after single 100 mg subcutaneous dose: results of a randomized, double-blind, crossover study in healthy volunteers
por: Martínez González, Javier, et al.
Publicado: (2018)

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis
por: Mehrotra, Siddharth, et al.
Publicado: (2022)

Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro
por: Tanaka, Kosuke, et al.
Publicado: (2018)

Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation
por: Patel, Priya, et al.
Publicado: (2019)

Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation
por: Walborn, Amanda, et al.
Publicado: (2019)

Osteopontin Levels in Patients With Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate With Intact Parathyroid Hormone and Alkaline Phosphatase
por: Druck, Aleksander, et al.
Publicado: (2019)

Biomarkers of Platelet Activation and Their Prognostic Value in Patients With Sepsis-Associated Disseminated Intravascular Coagulopathy
por: Wegrzyn, Gracelene, et al.
Publicado: (2021)

Cardiolipin Antibody: A Potential Biomarker for Depression
por: Costa, Renzo, et al.
Publicado: (2022)

Bioequivalence of a biosimilar enoxaparin (Cloti‐Xa™) and its innovator (Clexane(®)): A single‐dose, randomized, double‐blind, two‐period, two‐treatment, two‐sequence, crossover, balanced study in healthy human subjects
por: Saxena, Sumit, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
por: Phan, Trung, et al.
Publicado: (2020)

Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model
por: Shao, Huarui, et al.
Publicado: (2023)

Advances in Heparins and Related Research. An Epilogue
por: Fareed, Jawed, et al.
Publicado: (2018)

Inflammatory Biomarker Profiling in Total Joint Arthroplasty and Its Relevance to Circulating Levels of Lubricin, a Novel Proteoglycan
por: Galicia, Kevin, et al.
Publicado: (2018)

Matrix Metalloproteinases and Their Inhibitors and Proteoglycan 4 in Patients Undergoing Total Joint Arthroplasty
por: Thorson, Chase, et al.
Publicado: (2019)

Relationship Between 25-Hydroxyvitamin D, Renin, and Collagen Remodeling Biomarkers in Atrial Fibrillation
por: Patel, Dimpi, et al.
Publicado: (2020)

Interrelationship of Osteopontin, MMP-9 and ADAMTS4 in Patients With Osteoarthritis Undergoing Total Joint Arthroplasty
por: Slovacek, Hannah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73eh8ji40btmbkmqcl1ls5fuo4